PDS Biotechnology
Stock Forecast, Prediction & Price Target
PDS Biotechnology Financial Estimates
PDS Biotechnology Revenue Estimates
PDS Biotechnology EBITDA Estimates
PDS Biotechnology Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $275K Low: $275K High: $275K avg. 0% | Avg: $7.5M Low: $7.5M High: $7.5M avg. 2627.27% | Avg: $24.45M Low: $24.45M High: $24.45M avg. 226.04% | Avg: $87.34M Low: $87.34M High: $87.34M avg. 257.19% |
Net Income
% change YoY
| $-16.91M N/A | $-40.85M -141.48% | $-42.94M -5.10% | Avg: $-60.12M Low: $-60.97M High: $-30.02M avg. -40.02% | Avg: $-58.78M Low: $-37.14M High: $-32.49M avg. 2.23% | Avg: $-33.73M Low: $-33.73M High: $-33.73M avg. 42.61% | Avg: $-4.23M Low: $-4.23M High: $-4.23M avg. 87.46% |
EBITDA
% change YoY
| $-21.43M N/A | $-40.73M -90.05% | $-40.08M 1.60% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$0.66 N/A | -$1.43 -116.66% | -$1.39 2.79% | Avg: -$1.38 Low: -$1.97 High: -$0.97 avg. 0.71% | Avg: -$1.12 Low: -$1.2 High: -$1.05 avg. 19.20% | Avg: -$1.09 Low: -$1.09 High: -$1.09 avg. 2.24% | Avg: -$0.14 Low: -$0.14 High: -$0.14 avg. 87.46% |
Operating Expenses
% change YoY
| $21.43M N/A | $41.67M 94.37% | $43.04M 3.29% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is PDS Biotechnology stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 23.06% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -60.97M, average is -60.12M and high is -30.02M.
What is PDS Biotechnology stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 777.62% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $275K, average is $275K and high is $275K.
What is PDS Biotechnology stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 27.40% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$1.97, average is -$1.38 and high is $-0.97.
What is the best performing analyst?
In the last twelve months analysts have been covering PDS Biotechnology stock. The most successful analyst is Mayank Mamtani.